According to Jiang et al. [21, 25], patients were excluded if they were diagnosed with primary cutaneous T/natural killer-cell lymphomas or anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.